FINWIRES · TerminalLIVE
FINWIRES

Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target

By

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Research

Jefferies Initiates Coverage on Pershing Square USA With Buy Rating

$PSUS
Research

Morgan Stanley Initiates Avalyn Pharma at Overweight With $53 Price Target

$AVLN
Research

Keefe Bruyette & Woods Initiates Coverage on Pershing Square USA With Market Perform Rating, $42 Price Target

$PSUS